ZA935660B - Modified proteases. - Google Patents

Modified proteases.

Info

Publication number
ZA935660B
ZA935660B ZA935660A ZA935660A ZA935660B ZA 935660 B ZA935660 B ZA 935660B ZA 935660 A ZA935660 A ZA 935660A ZA 935660 A ZA935660 A ZA 935660A ZA 935660 B ZA935660 B ZA 935660B
Authority
ZA
South Africa
Prior art keywords
pct
modified
date feb
proteases
sec
Prior art date
Application number
ZA935660A
Other languages
English (en)
Inventor
Keith Martyn Dawson
Richard James Gilbert
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of ZA935660B publication Critical patent/ZA935660B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA935660A 1992-08-04 1993-08-14 Modified proteases. ZA935660B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216558A GB9216558D0 (en) 1992-08-04 1992-08-04 Modified proteases

Publications (1)

Publication Number Publication Date
ZA935660B true ZA935660B (en) 1994-03-17

Family

ID=10719807

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935660A ZA935660B (en) 1992-08-04 1993-08-14 Modified proteases.

Country Status (10)

Country Link
US (2) US5645833A (de)
EP (1) EP0658206B1 (de)
JP (1) JP3449717B2 (de)
AT (1) ATE282089T1 (de)
AU (1) AU4720093A (de)
DE (1) DE69333689T2 (de)
ES (1) ES2232812T3 (de)
GB (1) GB9216558D0 (de)
WO (1) WO1994003614A1 (de)
ZA (1) ZA935660B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7278094A (en) * 1994-06-07 1996-01-04 M D Serv Europe S.A. Intravasal thrombolysis
GB9412131D0 (en) * 1994-06-17 1994-08-10 British Bio Technology Thrombolytic composition
US6942978B1 (en) * 1999-03-03 2005-09-13 The Board Of Trustees Of The University Of Arkansas Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
US7700341B2 (en) * 2000-02-03 2010-04-20 Dendreon Corporation Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
JP2001275677A (ja) * 2000-03-30 2001-10-09 Canon Inc 核酸断片プライマーまたはプローブ、およびこれを用いたポリヒドロキシアルカノエート合成微生物の検出方法
EP1390497A2 (de) 2001-05-25 2004-02-25 Genset Menschliche cdns und proteine und verwendungen davon
DE102006053404A1 (de) * 2006-11-10 2008-05-15 Hydro Aluminium Alucast Gmbh Gießform zum Gießen eines Gussteils und Verwendung einer solchen Gießform
JP2018537976A (ja) * 2015-11-25 2018-12-27 アカデミシュ・ジークンホイス・ライデン 組換えセリンプロテアーゼ
US11613744B2 (en) 2018-12-28 2023-03-28 Vertex Pharmaceuticals Incorporated Modified urokinase-type plasminogen activator polypeptides and methods of use
EP3902913A1 (de) 2018-12-28 2021-11-03 Catalyst Biosciences, Inc. Modifizierte urokinaseartige plasminogenaktivatorpolypeptide und verfahren zur verwendung

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2007364A1 (en) * 1989-01-17 1990-07-17 David J. Livingston Gene sequences encoding modified residues situated in the protease domain of tpa
US5304482A (en) * 1989-03-06 1994-04-19 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors
EP1029921B1 (de) * 1989-03-06 2002-10-23 The Board of Regents of The University of Texas System Serpin-resistenter T-PA; Mutanten; Gene
GB8927722D0 (en) * 1989-12-07 1990-02-07 British Bio Technology Proteins and nucleic acids

Also Published As

Publication number Publication date
DE69333689D1 (de) 2004-12-16
GB9216558D0 (en) 1992-09-16
JPH07509610A (ja) 1995-10-26
AU4720093A (en) 1994-03-03
ATE282089T1 (de) 2004-11-15
US5932213A (en) 1999-08-03
WO1994003614A1 (en) 1994-02-17
EP0658206B1 (de) 2004-11-10
DE69333689T2 (de) 2005-11-03
JP3449717B2 (ja) 2003-09-22
EP0658206A1 (de) 1995-06-21
US5645833A (en) 1997-07-08
ES2232812T3 (es) 2005-06-01

Similar Documents

Publication Publication Date Title
MX9709915A (es) Heterociclos de peptidilo y composiciones que los contienen, utiles en el tratamiento de trastornos relacionados con trombina, y uso de los mismos.
DE69533472D1 (de) Kallikreinhemmende "kunitz-domäne"-proteine und derivaten davon
DE69033699D1 (de) Gegenüber eigenen inhibitoren resistente t-pa mutanten
EP0072947A3 (en) Agent for the prevention and treatment of liver and kidney diseases
GB9216558D0 (en) Modified proteases
MX9701514A (es) Limpieza, desinfeccion y preparacion de lentes de contacto.
WO1996024650A3 (en) Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences
HUT70215A (en) Thrombin inhibitors
DE69319337D1 (en) Polyetheramidoamine hydrogele als heparinersatz
ES2133328T3 (es) Enzimas de detergente de verticillium.
FI951078A0 (fi) Retrovirusinfektion inhibitio
GR3024267T3 (en) Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor.
MXPA03010380A (es) Uso de inhibidores de la proteasa para el virus de inmunodeficiencia humana (vih) para bloquear la migracion y/o invasion de celulas, infiltracion de tejido y formacion de edema.
ES2080657A1 (es) Proteasas modificadas.
BR9608978A (pt) Inibidor de protease de serina derivado de imidazo [1,5a] piridina composição farmacêutica e utilização do inibidor de protease
TW288046B (en) Nucleotide sequence of cDNA of a thrombin-like enzyme (ancrod) from Calloselasma rhodostoma and amino acid sequence of ancrod therefrom
FR2657005B1 (fr) Systeme d'enclouage pour le traitement des fractures notamment du type cervico-trochanteriennes et pertrochanteriennes.
SI0828483T1 (en) Use of tropolone derivatives as inhibitors of the enzyme inositol monophosphatase
DE59813159D1 (de) Kombination der proteolytischen enzyme trypsin, bromelain und papain zur behandlung von glomerulonephritis
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs